1. Home >
  2. M&A >
  3. Growth Capital >
  4. United Kingdom >
  5. Calculus Capital Invests In Smartr365

Investment Summary

Calculus Capital Invests In Smartr365

On January 22, 2025, private equity firm Calculus Capital invested in information technology company Smartr365

Investment Highlights
  • This is Calculus Capital’s 4th transaction in the Information Technology sector.
  • This is Calculus Capital’s 43rd transaction in the United Kingdom.

Investment Summary
Date 2025-01-22
Target Smartr365
Sector Information Technology
Investor(s) Calculus Capital
Deal Type Growth Capital

Target

Smartr365

London, United Kingdom
Smartr365 is a mortgage technology CRM and platform that unites mortgage advisers and state-of the-art technology to empower better financial decisions and planning for clients. The company gives clients access to all of their financial data – mortgages/insurance/pensions/investments – all in one place. Smartr365 is based in London.

Search 205,333 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

Calculus Capital

Investor Investor Investor Investor

Category Private Equity Firm
Founded 1999
Size Small
Type Sector Agnostic
DESCRIPTION

Calculus Capital is a UK-based investment group focused on fast-growth companies. Calculus Capital is sector agnostic and looks to commit £2 to £5 million per investment. Calculus Capital is based in London.

DEAL STATS #
Overall 45 of 45
Sector (Information Technology) 4 of 4
Type (Growth Capital) 28 of 28
Country (United Kingdom) 43 of 43
Year (2025) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2023-09-28 Laverock Therapeutics

Stevenage, United Kingdom

Laverock Therapeutics is a gene editing-induced gene silencing (GEiGS) platform for all human therapeutic applications. Laverock Therapeutics was founded in 2021 and is based in Stevenage, United Kingdom.

Buy -
Mergr

Product

Company

Legal